Vertex Pharmaceuticals Inc. buy Guggenheim
Start price
02.08.24
/
50%
€453.20
Target price
02.08.25
€511.18
Performance (%)
0.00%
Price
02.08.24
€453.20
Summary
This prediction is currently active. Guggenheim's BUY prediction for Vertex Pharmaceuticals Inc. is currently unchanged. This prediction currently runs until 02.08.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Vertex Pharmaceuticals Inc. | 0.00% |
iShares Core DAX® | -1.377% |
iShares Nasdaq 100 | 0.827% |
iShares Nikkei 225® | 0.198% |
iShares S&P 500 | 1.364% |
Comments by Guggenheim for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Guggenheim from $450.00 to $558.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat